Table 1 Myriad tumour BRCA status compared with Foundation Medicine tumour BRCA status
From: Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Myriad tBRCA status | Foundation Medicine tBRCA status | |||
BRCAm | BRCAwt | Missing | Total | |
BRCAm | 106 | 3 | 9 | 118 |
BRCAwt | 0 | 84 | 10 | 94 |
Missing | 5 | 11 | 37 | 53 |
Total | 111 | 98 | 56 | 265 |
